Craft

Eris Lifesciences

Stock Price

₹1.3 K

2024-10-29

Market Capitalization

₹176.3 B

2024-10-29

Revenue

₹28.8 B

FY, 2025

Eris Lifesciences Summary

Company Summary

Overview
Eris Lifesciences is a company specializing in the chronic and acute therapy segments. It manufactures and sells products across a range of areas, including diabetes, gastroenterology, nephrology, gynaecology, paediatrics, orthopaedics, pain management, oncology, infertility management, psychiatry, etc.
Type
Public
Status
Active
Founded
2007
HQ
Ahmedabad, IN | view all locations
Website
https://eris.co.in/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Amit Bakshi

    Amit Bakshi, Chairman and Managing Director

    • Vijaya Sampath

      Vijaya Sampath, Independent Director

      • Kaushal Kamlesh Shah

        Kaushal Kamlesh Shah, Executive Director

        • Prashant Gupta

          Prashant Gupta, Independent Director

          LocationsView all

          4 locations detected

          • Ahmedabad, GJ HQ

            India

            10, Zydus Hospital Rd, Thaltej

          • Ambala Cantt, HR

            India

            91-92, Naggal

          • Guwahati, AS

            India

            Barpeta Daulshal Hojo Rd, Amingaon

          • Mumbai, MH

            India

            G Block Rd, G Block BKC, Bandra Kurla Complex, Bandra East

          Eris Lifesciences Financials

          Summary Financials

          Revenue (Q3, 2026)
          ₹8.0B
          Gross profit (Q3, 2026)
          ₹5.8B
          Net income (Q3, 2026)
          ₹1.1B
          Cash (Q2, 2026)
          ₹697.5M
          EBIT (Q3, 2026)
          ₹1.9B
          Enterprise value
          $199.5B

          Footer menu